Portola Pharmaceuticals Submits New Drug Application to U.S. FDA for Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism in Acute Medically Ill Patients

World News: . []

SOUTH SAN FRANCISCO Calif Oct 25 2016 GLOBE NEWSWIRE -- Portola Pharmaceuticals Inc NasdaqPTLA today announced that it has submitted a New Drug Application NDA to the US Food and Drug Administration FDA seeking approval to market betrixa...

More news and information about Portola Pharmaceuticals, Inc.

Published By:

Globe Newswire: 13:00 GMT Tuesday 25th October 2016

Published: .

Search for other references to "portola" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us